Heparin cofactor II in diabetic patients

Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83±7%) in patients with high levels...

Descripción completa

Guardado en:

Detalles Bibliográficos
Publicado:	1994
Materias:	crossed immunoelectrophoresis diabetes heparin cofactor II glycosylated hemoglobin adult article controlled study diabetes mellitus female human immunoassay major clinical study male priority journal
Acceso en línea:	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09575235_v5_n2_p201_Duboscq http://hdl.handle.net/20.500.12110/paper_09575235_v5_n2_p201_Duboscq
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	paper:paper_09575235_v5_n2_p201_Duboscq
record_format	dspace
spelling	paper:paper_09575235_v5_n2_p201_Duboscq2023-06-08T15:56:38Z Heparin cofactor II in diabetic patients crossed immunoelectrophoresis diabetes heparin cofactor II glycosylated hemoglobin heparin cofactor II adult article controlled study diabetes mellitus female human immunoassay major clinical study male priority journal Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83±7%) in patients with high levels of glycosylated haemoglobin compared with controls (95±17%; P<0.001). However, plasma HCII antigen levels were not decreased in these patients. 1994 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09575235_v5_n2_p201_Duboscq http://hdl.handle.net/20.500.12110/paper_09575235_v5_n2_p201_Duboscq
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	crossed immunoelectrophoresis diabetes heparin cofactor II glycosylated hemoglobin heparin cofactor II adult article controlled study diabetes mellitus female human immunoassay major clinical study male priority journal
spellingShingle	crossed immunoelectrophoresis diabetes heparin cofactor II glycosylated hemoglobin heparin cofactor II adult article controlled study diabetes mellitus female human immunoassay major clinical study male priority journal Heparin cofactor II in diabetic patients
topic_facet	crossed immunoelectrophoresis diabetes heparin cofactor II glycosylated hemoglobin heparin cofactor II adult article controlled study diabetes mellitus female human immunoassay major clinical study male priority journal
description	Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83±7%) in patients with high levels of glycosylated haemoglobin compared with controls (95±17%; P<0.001). However, plasma HCII antigen levels were not decreased in these patients.
title	Heparin cofactor II in diabetic patients
title_short	Heparin cofactor II in diabetic patients
title_full	Heparin cofactor II in diabetic patients
title_fullStr	Heparin cofactor II in diabetic patients
title_full_unstemmed	Heparin cofactor II in diabetic patients
title_sort	heparin cofactor ii in diabetic patients
publishDate	1994
url	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09575235_v5_n2_p201_Duboscq http://hdl.handle.net/20.500.12110/paper_09575235_v5_n2_p201_Duboscq
_version_	1768544966121881600

Heparin cofactor II in diabetic patients

Ejemplares similares